METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat gut tumors: drug blocks cancer growth
Disease control OngoingThis study tests the drug abemaciclib in 20 people with advanced digestive neuroendocrine tumors that have spread, stopped responding to standard treatment, and cannot be removed by surgery. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it …
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New hope for neuroendocrine tumors: cabozantinib shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests the drug cabozantinib against a placebo in 298 people with advanced neuroendocrine tumors (including carcinoid tumors) that have worsened after prior treatment. Cabozantinib is a targeted therapy that may slow or stop tumor growth by blocking certain prot…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug combo shows promise for rare gut tumors
Disease control OngoingThis early-stage trial tests a new two-drug combination for people with advanced neuroendocrine tumors (NETs) that have spread. The study combines triapine, which may slow tumor growth, with a radioactive drug called lutetium Lu 177 dotatate that targets tumor cells directly. Abo…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:52 UTC